Filter News
Area of Research
- Advanced Manufacturing (3)
- Biology and Environment (9)
- Clean Energy (14)
- Computational Engineering (1)
- Computer Science (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (9)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (6)
- Materials (14)
- Materials for Computing (2)
- National Security (16)
- Neutron Science (7)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Supercomputing (22)
News Type
News Topics
- (-) Advanced Reactors (10)
- (-) Artificial Intelligence (29)
- (-) Biomedical (17)
- (-) Clean Water (1)
- (-) Cybersecurity (17)
- (-) Isotopes (17)
- (-) Nuclear Energy (25)
- 3-D Printing/Advanced Manufacturing (44)
- Big Data (8)
- Bioenergy (24)
- Biology (22)
- Biotechnology (7)
- Buildings (13)
- Chemical Sciences (29)
- Climate Change (22)
- Composites (9)
- Computer Science (57)
- Coronavirus (17)
- Critical Materials (11)
- Decarbonization (18)
- Education (3)
- Element Discovery (1)
- Energy Storage (41)
- Environment (36)
- Exascale Computing (9)
- Fossil Energy (1)
- Frontier (14)
- Fusion (14)
- Grid (15)
- High-Performance Computing (26)
- ITER (2)
- Machine Learning (13)
- Materials (59)
- Materials Science (50)
- Mercury (2)
- Microscopy (16)
- Molten Salt (2)
- Nanotechnology (26)
- National Security (18)
- Net Zero (3)
- Neutron Science (49)
- Partnerships (26)
- Physics (24)
- Polymers (12)
- Quantum Computing (9)
- Quantum Science (26)
- Renewable Energy (1)
- Security (11)
- Simulation (8)
- Space Exploration (3)
- Statistics (2)
- Summit (20)
- Sustainable Energy (31)
- Transformational Challenge Reactor (4)
- Transportation (24)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
OAK RIDGE, Tenn., Feb. 19, 2020 — The U.S. Department of Energy’s Oak Ridge National Laboratory and the Tennessee Valley Authority have signed a memorandum of understanding to evaluate a new generation of flexible, cost-effective advanced nuclear reactors.
Oak Ridge National Laboratory will give college students the chance to practice cybersecurity skills in a real-world setting as a host of the Department of Energy’s fifth collegiate CyberForce Competition on Nov. 16. The event brings together student teams from across the country to compete at 10 of DOE’s national laboratories.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
The U.S. Department of Energy announced funding for 12 projects with private industry to enable collaboration with DOE national laboratories on overcoming challenges in fusion energy development.
Processes like manufacturing aircraft parts, analyzing data from doctors’ notes and identifying national security threats may seem unrelated, but at the U.S. Department of Energy’s Oak Ridge National Laboratory, artificial intelligence is improving all of these tasks.
The National Alliance for Water Innovation, a partnership of the Department of Energy’s Oak Ridge National Laboratory, other national labs, university and private sector partners, has been awarded a five-year, $100 million Energy-Water Desalination Hub by DOE to address water security issues in the United States.
Three researchers at Oak Ridge National Laboratory will lead or participate in collaborative research projects aimed at harnessing the power of quantum mechanics to advance a range of technologies including computing, fiber optics and network
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.